[Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].

Source:http://linkedlifedata.com/resource/pubmed/id/15631714

Download in:

View as

General Info

PMID
15631714